Explore tirzepatide’s unique dual GIP and GLP-1 receptor agonism, the SURMOUNT-1 trial’s 22.5% weight loss results, dosing schedule, and differences between Mounjaro and Zepbound.
標籤彙整: SURMOUNT trial
The Science Behind the Weight Loss Numbers: STEP and SURMOUNT Trial Results Explained
A plain-language breakdown of the STEP (semaglutide) and SURMOUNT (tirzepatide) Phase 3 clinical trials: design, results, limitations, and what the weight loss percentages really mean for patients.